Sunwin Stevia International (SUWN) Gross Profit Margin starting from the second quarter 2022 to second quarter 2021, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Sunwin Stevia International Inc.  (SUWN)


Sunwin Stevia International's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SUWN Gross Profit Margin (Oct 31 2022)
Q2 		(Jul 31 2022)
Q1 		(Apr 30 2022)
Q4 		(Jan 31 2022)
Q3 		(Oct 31 2021)
Q2
Y / Y Revenue Change -26.76 %
Seq. Revenue Change -3.98 %
Revenue In Millions $7.40
Gross Profit Margin 17.24 %
Gross Profit Margin Total Ranking # 3573
Gross Profit In Millions $1.28
Y / Y Gross Profit Change -
Seq. Gross Profit Change 10.39 %


Commenting Second Quarter 2022 Gross Profit Margin
Sunwin Stevia International Inc. achieved Gross Profit of $1 millions compare to Gross Loss of $1.16 millions booked in the previous quarter. Despite the sequential Revenue deterioration in Q2 of -3.98 % Sunwin Stevia International Inc. managed to reduce Cost of Sales and increase Gross Profit by 10.39 % to $1 millions. Gross Profit Margin grew to 17.24 %, above company average Gross Profit Margin.


Observing second quarter 2022 results within Major Pharmaceutical Preparations industry 172 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 3407 to 3573.
Learn about Gross Margin
SUWN's Gross Profit Margin second quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 173
Healthcare Sector # 519
Overall # 3499

Gross Profit Margin Statistics
High Average Low
26.7 % 13.93 % 0.91 %
(Apr 30 2015)   (Oct 31 2017)


SUWN Gross Income Trends • More of SUWN's Profitabilty Ratios • SUWN Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
SUWN's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
SUWN's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for SUWN's Competitors
Gross Profit Margin Profit Margin for Sunwin Stevia International's Suppliers
Gross Profit Margin Profit Margin for SUWN's Customers

You may also want to know
SUWN's Annual Growth Rates SUWN's Profitability Ratios SUWN's Asset Turnover Ratio SUWN's Dividend Growth
SUWN's Roe SUWN's Valuation Ratios SUWN's Financial Strength Ratios SUWN's Gross Profit Growth
SUWN's Roa SUWN's Inventory Turnover Ratio SUWN's Growth Rates SUWN's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Oct 31 2022, within Major Pharmaceutical Preparations Industry Gross Profit MarginOct 31 2022 MRQ Gross ProfitOct 31 2022 MRQ Revenue
Royalty Pharma Plc  46.80 %$ 268.402  Millions$ 573.463  Millions
Schrodinger Inc   46.51 %$ 17.201  Millions$ 36.980  Millions
Teva Pharmaceutical Industries Limited  46.43 %$ 1,669.000  Millions$ 3,595.000  Millions
Collegium Pharmaceutical Inc   46.33 %$ 58.839  Millions$ 127.013  Millions
Gelesis Holdings Inc   45.64 %$ 3.036  Millions$ 6.652  Millions
Heron Therapeutics Inc   44.58 %$ 11.840  Millions$ 26.557  Millions
Serina Therapeutics Inc   44.44 %$ 0.004  Millions$ 0.009  Millions
Cryoport inc   43.69 %$ 26.417  Millions$ 60.464  Millions
Viatris Inc   42.87 %$ 1,748.400  Millions$ 4,078.200  Millions
Cv Sciences Inc   41.64 %$ 1.562  Millions$ 3.751  Millions
Orgenesis Inc   41.59 %$ 3.322  Millions$ 7.988  Millions
Uniqure N v   40.58 %$ 0.588  Millions$ 1.449  Millions
Camp4 Therapeutics Corporation  39.84 %$ 29.012  Millions$ 72.828  Millions
Amneal Pharmaceuticals Inc   35.69 %$ 194.230  Millions$ 544.230  Millions
Longeveron Inc   34.72 %$ 0.092  Millions$ 0.265  Millions
Ainos Inc   33.10 %$ 0.582  Millions$ 1.758  Millions
Perrigo Company Plc  32.99 %$ 362.900  Millions$ 1,099.900  Millions
Phibro Animal Health Corporation  29.52 %$ 68.646  Millions$ 232.521  Millions
Opko Health Inc   28.69 %$ 51.562  Millions$ 179.744  Millions
One World Products Inc   28.18 %$ 0.009  Millions$ 0.033  Millions
One World Products Inc   28.18 %$ 0.009  Millions$ 0.033  Millions
Aditxt Inc   27.68 %$ 0.089  Millions$ 0.323  Millions
Societal Cdmo Inc   25.63 %$ 5.534  Millions$ 21.589  Millions
Catalent Inc   25.24 %$ 258.000  Millions$ 1,022.000  Millions
Akebia Therapeutics Inc   22.50 %$ 11.017  Millions$ 48.964  Millions
Soligenix inc   22.09 %$ 0.037  Millions$ 0.166  Millions
Hcw Biologics Inc   20.00 %$ 0.362  Millions$ 1.809  Millions
Veru Inc   19.52 %$ 0.505  Millions$ 2.589  Millions
Athenex Inc   17.28 %$ 5.794  Millions$ 33.530  Millions
Sunwin Stevia International Inc.  17.24 %$ 1.276  Millions$ 7.403  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.